Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $428.12 | 5 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Melinta Therapeutics, Inc. | $246.00 | 2 | $0 (2019) |
| Allergan Inc. | $103.32 | 1 | $0 (2019) |
| TETRAPHASE PHARMACEUTICALS, INC. | $65.71 | 1 | $0 (2019) |
| GlaxoSmithKline, LLC. | $13.09 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $415.03 | 4 | Melinta Therapeutics, Inc. ($246.00) |
| 2018 | $13.09 | 1 | GlaxoSmithKline, LLC. ($13.09) |
All Payment Transactions
5 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/26/2019 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $103.32 | General |
| Category: ANTI-INFECTIVE | ||||||
| 06/11/2019 | Melinta Therapeutics, Inc. | Vabomere (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: ANTIBIOTICS | ||||||
| 03/27/2019 | TETRAPHASE PHARMACEUTICALS, INC. | Xerava (Drug) | Food and Beverage | In-kind items and services | $65.71 | General |
| Category: Complicated Intra-Abdominal Infections | ||||||
| 01/23/2019 | Melinta Therapeutics, Inc. | VABOMERE (Drug) | Food and Beverage | In-kind items and services | $121.00 | General |
| Category: ANTIBIOTICS | ||||||
| 08/25/2018 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $13.09 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 325 | 440 | $142,955 | $52,807 |
| 2022 | 7 | 311 | 430 | $136,249 | $51,215 |
| 2021 | 8 | 314 | 442 | $135,252 | $49,788 |
| 2020 | 9 | 241 | 298 | $73,395 | $25,362 |
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 70 | 139 | $67,971 | $21,829 | 32.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 76 | 112 | $40,768 | $11,265 | 27.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 64 | 64 | $10,688 | $10,017 | 93.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 59 | 69 | $17,043 | $4,818 | 28.3% |
| 90671 | Pneumococcal conjugate vaccine, 15 valent (pcv15), for intramuscular use | Office | 2023 | 11 | 11 | $3,575 | $2,654 | 74.2% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 15 | 15 | $1,350 | $1,137 | 84.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 17 | 17 | $1,105 | $631.38 | 57.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 13 | 13 | $455.00 | $456.30 | 100.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 78 | 161 | $76,475 | $25,199 | 33.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 69 | 69 | $10,902 | $10,759 | 98.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 70 | 101 | $35,653 | $9,647 | 27.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 35 | 40 | $9,600 | $2,888 | 30.1% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 18 | 18 | $1,512 | $1,265 | 83.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 23 | 23 | $1,495 | $844.03 | 56.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 18 | 18 | $612.00 | $612.91 | 100.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 79 | 145 | $66,845 | $22,172 | 33.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 75 | 133 | $45,619 | $12,266 | 26.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 66 | 66 | $9,504 | $9,504 | 100.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 34 | 38 | $8,854 | $2,689 | 30.4% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2021 | 11 | 11 | $1,529 | $1,379 | 90.2% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 17 | 17 | $1,173 | $1,109 | 94.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 21 | 21 | $1,365 | $439.32 | 32.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2021 | 11 | 11 | $363.00 | $229.79 | 63.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 79 | 116 | $38,164 | $10,907 | 28.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 32 | 32 | $4,480 | $4,445 | 99.2% |
About Dr. Lisa Tsang, M.D
Dr. Lisa Tsang, M.D is a Internal Medicine healthcare provider based in Daly City, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/13/2016. The National Provider Identifier (NPI) number assigned to this provider is 1871949347.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lisa Tsang, M.D has received a total of $428.12 in payments from pharmaceutical and medical device companies, with $415.03 received in 2019. These payments were reported across 5 transactions from 4 companies. The most common payment nature is "Food and Beverage" ($428.12).
As a Medicare-enrolled provider, Tsang has provided services to 1,191 Medicare beneficiaries, totaling 1,610 services with total Medicare billing of $179,173. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Daly City, CA
- Active Since 05/13/2016
- Last Updated 06/03/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1871949347
Products in Payments
- Vabomere (Drug) $125.00
- VABOMERE (Drug) $121.00
- AVYCAZ (Drug) $103.32
- Xerava (Drug) $65.71
- BENLYSTA (Biological) $13.09
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Daly City
Kevin Wong, M.d, M.D
Internal Medicine — Payments: $45,517
Tony Wong, M.d, M.D
Internal Medicine — Payments: $40,235
Dr. John Lai, M.d, M.D
Internal Medicine — Payments: $39,667
Dr. Alice Yan, M.d, M.D
Internal Medicine — Payments: $22,968
Damon Lee, Md, MD
Internal Medicine — Payments: $20,608
Dr. Shu May Lee, M.d, M.D
Internal Medicine — Payments: $18,620